Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stock Market Casualties You Can’t Ignore Today. Hims &…
/PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn…
Earlier in March 2026, Novo Nordisk agreed to resume selling its weight-loss drugs through the Hims & Hers Health platform,…
Hims & Hers Health ( ($HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual…
On March 17, 2026, Irene Becklund, a key figure at Hims & Hers Health Inc (HIMS), executed a sale of…
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $23.15, indicating a -7.33% shift from…
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $23.15, indicating a -7.33% shift from…
Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Irene Becklund sold 5,529 shares of Hims & Hers…
Hims & Hers health COO Chi sells $2.4m in shares…
Hims & Hers Health Inc. stocks have been trading down by -7.09% amid investor concerns about CEO leadership changes. Key…
Hims & Hers (HIMS) 2026 Deep Dive: The $1.15B Eucalyptus Deal and the Branded Pivot…
In collaboration with Novo Nordisk, Hims & Hers soon will offer access to the only FDA-approved GLP-1 weight loss pill,…
Novo Nordisk believes that by marketing such untested medicines, Hims & Hers is exposing patients to drugs that may contain…
Greenfield Seitz Capital Management LLC lowered its holdings in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by…
Hims & Hers Health, Inc. (NYSE:HIMS) trended on Wednesday after the company outlined an expanded weight-management push tied to…
The stock price of telemedicine platform Hims & Hers (HIMS) has experienced fluctuations over the past few years. The stock…
Novo Nordisk (CPSE:NOVO B) has entered a partnership with Hims & Hers to provide access to its FDA approved GLP-1…
LOS ANGELES, March 17, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Hims & Hers Health, Inc.,…
Die Partnerschaft zwischen Hims & Hers und Novo Nordisk markiert einen Wendepunkt in der noch jungen Geschichte der digitalen Gesundheitsplattform.…
Novo Nordisk A/S (NYSE:NVO) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March…
Aquatic Capital Management LLC acquired a new position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in…
Hims & Hers Health (NYSE:HIMS) is expanding into complex health categories such as cancer care, longevity treatments, and at-home lab…
Novo Nordisk partners with Hims & Hers to supply FDA-approved GLP-1 drugs Ozempic and Wegovy, replacing compounded versions amid market…
Hims & Hers Health ist eine Telemedizin-Plattform, die personalisierte Behandlungen digital zugänglich macht. Am 9. März sahen wir einen massiven…
The drama and uncertainty around Novo Nordisk and Hims & Hers Health might finally be ending.…
The drama and uncertainty around Novo Nordisk and Hims & Hers Health might finally be ending.…
The drama and uncertainty around Novo Nordisk and Hims & Hers Health might finally be ending.…
Hims & Hers Health Inc (NYSE: HIMS) shares are pulling back Monday morning, giving back a portion of last weeks…
Leerink analyst Michael Cherny raised the firm’s price target on Hims Hers to $25 from $17.50 and keeps a…
Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight…
Earlier this month, Hims & Hers Health, Inc. resolved its legal dispute with Novo Nordisk and entered a renewed collaboration…
Is HIMS a good stock to buy? We came across a bullish thesis on Hims & Hers Health, Inc. on…
Is HIMS a good stock to buy? We came across a?bullish thesis?on Hims & Hers Health, Inc. on TopSecretStocks’s Substack by…
Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stocks Making Huge Moves this Week. Hims & Hers…
Why Hims & Hers Health (HIMS) is on investors’ radarHims & Hers Health (HIMS) has drawn fresh attention after a…
Hims & Hers (HIMS) stock surged 57% this week to record its best weekly rise after reaching a deal with…
Hims & Hers Health (NYSE:HIMS) has agreed to acquire Australian digital health company Eucalyptus, advancing its international expansion beyond the…
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 11 Best Day Trading Stocks to Buy Now. Investment bank…
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the 12 Most Shorted Stocks to Buy in 2026. On March…
Bloomberg journalists discuss todays biggest winners and losers in the stock market. Listen for analysis on the companies making news…
A new class action lawsuit alleges Hims & Hers falsely advertises its compounded GLP-1 semaglutide products as being the same…
Hims & Hers Health Inc. shares are on pace for their best week on record as a new partnership with…
Hims & Hers Health Inc. shares posted their best week on record as a new partnership with Novo Nordisk A/S…
Novo Nordisk dropped its lawsuit against Hims & Hers and launched a new collaboration. The deal is advantageous for both…
Hims & Hers Health, Inc. (HIMS) closed at $23.84 in the latest trading session, marking a -7.88% move from the…
Hims & Hers Health (NYSE:HIMS) launched the Hims & Hers Benefits program, expanding its subscription platform beyond prescriptions.The program gives…
Shares of Hims & Hers Health NYSE:HIMS climbed about 5% on Thursday morning after the telehealth company said it entered…
Beiser joins the telehealth company from Eli Lilly as it expands internationally and builds out its Phoenix operations.…
Hims & Hers shares extend gains as Eli Lilly warns impurity it discovered in compounded versions of its weight-loss drug…
Hims & Hers Health (NYSE:HIMS) looked like a fallen growth star earlier this year. The telehealth platform was hammered by…